Tentt

XOMA Royalty Acquired by Ligand Pharmaceuticals | Financial Services M&A Deal

Announced
Financial ServicesFloridaMerger

Deal Summary

Ligand Pharmaceuticals to acquire XOMA Royalty for about $739M in cash, adding a large biopharma royalty portfolio and CVR tied to litigation proceeds.

Key Details

Transaction
Ligand Pharmaceuticals acquires XOMA Royalty
Deal Size
Over $100M
Reported Value
$739 million

Source

Read full article on globenewswire.com

via GlobeNewswire — M&A · April 27, 2026

Powered by Tentt

Source financial services deals in Florida for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call